Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Whole genome sequencing of Kazachstania humilis and Kazachstania bulderi

PROVIDER: PRJEB44438 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
		Other
	ERR5775463_1.fastq.gz	Fastqsanger.gz
	ERR5775463_2.fastq.gz	Fastqsanger.gz
	ERR5775464_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 10

Similar Datasets

Project description:Kazachstania bulderi genome assembly

| PRJNA929900 | ENA

Maudiozyma humilis

Project description:Kazachstania humilis overview

| PRJNA768519 | ENA

Maudiozyma humilis strain:MAW1

Project description:Kazachstania humilis MAW1 genome sequencing and assembly

| PRJNA785806 | ENA

Maudiozyma humilis strain:YMX003162

Project description:Draft genome sequence of Kazachstania humilis YMX003162

| PRJNA765342 | ENA

Maudiozyma humilis strain:YMX000554

Project description:Draft genome sequences of Kazachstania humilis YMX000554

| PRJNA765336 | ENA

Maudiozyma humilis strain:YMX000387

Project description:Draft genome sequences of Kazachstania humilis YMX000387

| PRJNA765338 | ENA

Maudiozyma humilis strain:YMX004033

Project description:Draft genome sequence of Kazachstania humilis YMX004033

| PRJNA765343 | ENA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

Project description:Shotgun metagenomic sequencing of strong-flavor Baijiu fermentation with Kazachstania bulderi FJ1-3 inoculation

| PRJNA1449785 | ENA

Project description:Shotgun metagenomic sequencing of strong-flavor Baijiu fermentation without Kazachstania bulderi FJ1-3 inoculation

| PRJNA1449713 | ENA